T-DM1 update from Roche
 

Some of you may have already seen this Roche update on the T-DM1 trial that's comparing the conjugate drug against the first line treatment of metastatic breast cancer of Herceptin plus docetaxol. The early results thus far at 5.9 months follow-up show comparable tumor shrinkage, and the trial drug shows fewer side effects.

This press release also contains ovarian cancer trial information.

http://www.roche.com/media/media_rel...010-10-11b.htm

Joan

Re: T-DM1 update from Roche
 

Thanks Joan !!
We are always interested in T DM1 news.

Re: T-DM1 update from Roche
 

T DM1 clinical trials

http://www.clinicaltrials.gov/ct2/re...linical+trials